CT
DGX icon

Caldwell Trust’s Quest Diagnostics DGX Stock Holding History

Caldwell Trust’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.79M Buy
13,165
+276
+2% +$54.2K 0.23% 92
2026
Q1 		$2.53M Buy
12,889
+2,010
+18% +$391K 0.23% 94
2025
Q4 		$1.89M Buy
10,879
+3,085
+40% +$562K 0.17% 106
2025
Q3 		$1.49M Buy
7,794
+5,869
+305% +$1.04M 0.14% 134
2025
Q2 		$346K Buy
1,925
+1,479
+332% +$257K 0.03% 254
2025
Q1 		$75.5K Buy
+446
New +$73.3K 0.01% 406

Other funds holding DGX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

Caldwell Trust's DGX Position: Q2 2026 in Review

Caldwell Trust increased its Quest Diagnostics (DGX) stake by 2.1% in Q2 2026, buying an estimated $54.2K and bringing the position to 13,165 shares worth $2.79M. The position accounts for 0.23% of the portfolio, ranked #92.

Caldwell Trust first reported a position in DGX in Q1 2025 and has held it in 6 quarters since. 1,105 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Caldwell Trust held 13,165 shares of Quest Diagnostics worth $2.79M as of Q2 2026.
  • Caldwell Trust bought 276 Quest Diagnostics shares in Q2 2026, an estimated $54.2K.
  • Quest Diagnostics made up 0.23% of Caldwell Trust's portfolio in Q2 2026, its #92 holding.
  • Caldwell Trust first reported a position in Quest Diagnostics in Q1 2025 and has held it in 6 quarters since.
  • 1,105 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Caldwell Trust's 13F filing for Q2 2026, filed 3 Aug 2026.